INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 25 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,165,000 | -25.4% | 729,193 | +25.9% | 0.08% | -20.6% |
| Q1 2019 | $4,245,000 | -2.8% | 579,193 | 0.0% | 0.10% | +3.0% |
| Q4 2018 | $4,367,000 | +31.0% | 579,193 | -1.8% | 0.10% | +43.5% |
| Q3 2018 | $3,333,000 | +45.1% | 589,996 | +13.0% | 0.07% | +25.5% |
| Q2 2018 | $2,297,000 | -30.4% | 522,067 | 0.0% | 0.06% | -29.5% |
| Q1 2018 | $3,302,000 | +22.8% | 522,067 | 0.0% | 0.08% | +16.4% |
| Q4 2017 | $2,689,000 | -42.5% | 522,067 | 0.0% | 0.07% | -39.6% |
| Q3 2017 | $4,673,000 | +57.0% | 522,067 | -0.0% | 0.11% | +63.2% |
| Q2 2017 | $2,977,000 | +17.1% | 522,200 | +5.0% | 0.07% | +11.5% |
| Q1 2017 | $2,542,000 | -12.7% | 497,200 | +0.4% | 0.06% | -26.5% |
| Q3 2016 | $2,911,000 | +27.8% | 495,000 | 0.0% | 0.08% | +31.7% |
| Q2 2016 | $2,277,000 | – | 495,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |